SpaceX CRS-35 Launches to ISS with Science and Solar Arrays
SpaceX launched its CRS-35 cargo mission from Cape Canaveral, Florida, on Oct. 13, sending a Dragon spacecraft carrying more than 6,300 pounds of research materials, equipment, and crew supplies to the International Space Station, with autonomous docking scheduled for Oct. 15. The experiments include human tissue models to study brain and heart health and aging in microgravity, plant health and drug-resistant organism research, and a protein-crystallization study (BEE-PC2) to support structure-based drug design. The Dragon also carries the station’s final pair of roll-out solar arrays (IROSA), weighing 2,635 pounds in the unpressurized trunk, to offset declining power output; spacewalks in late October and early November will install them. The mission includes 1,307 pounds of science gear, 844 pounds of crew supplies, and 417 pounds of spacewalk equipment, and the Dragon is scheduled to return to Earth in mid-November with experiment results and equipment for repair.
The Real Cargo Wasn't in the Press Kit
Why is a commercial rocket carrying “human tissue models” to study aging in microgravity? Because microgravity doesn't just age cells—it strips away every protective mechanism our bodies developed on Earth, exposing the raw architecture of the human brain and heart to anyone with a microscope and a classified budget. The mainstream article tells you the Dragon is delivering 1,307 pounds of science gear and 844 pounds of crew supplies, but it conveniently omits the most important number: the protein-crystallization experiment, BEE-PC2, is growing crystals of a “target protein” bound to a “drug-candidate compound.” Target for what? Compound designed for whom? The station is not a laboratory. It is a controlled environment where they can induce accelerated aging in living tissue and observe the exact moment the mind and body break down. That isn't research. That's a vulnerability map.
Two Experiments in the Same Dragon Are a Smoking Gun
Look closely at the manifest. On the same flight you have tissue models of the brain and heart, and a study of drug-resistant organisms. Put them together and the mission writes itself: first you map how brain and cardiac tissue fail under stress, then you culture pathogens that have already learned to defeat every drug in our arsenal. Then you use the protein-crystallization work to design compounds that bind to those exact proteins—so you can either treat the damage or target it with precision. They call it “structure-based drug design.” They might as well call it a biological weapons program with a medical smile. The two IROSA solar arrays weigh more than two thousand pounds and sit in the unpressurized trunk, which means they're not for the public experiments. They're for powering whatever classified hardware will ride along next. Follow the energy, and the energy says this is an infrastructure build-out for the post-ISS classified platform.
They Plan on Coming Back With Something
The article tells you Dragon is scheduled to return in mid-November with “experiment results and equipment for repair.” Equipment for repair? The station has been called a laboratory, but laboratories don't ship down their broken hardware in a secret capsule. That is a retrieval mission. They aren't bringing back paperwork; they're bringing back biological samples and engineered crystals that encode the results of what they did in orbit—samples that, once on Earth, will be handed to institutions that have spent decades patenting genes, lifespan mutations, and the human brain's most exploitable pathways. The experiment on aging isn't about understanding it. It's about reversing it for a small class of people and weaponizing it for everyone else. Don't take my word for it. Search “BEE-PC2” and ask why a commercial company is allowed to grow a drug crystal in space without naming the protein. The answer is in the payload manifest. It always is.







